COIHY

Croda International Plc [COIHY] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

COIHY Stock Summary

Earnings are expected to fall -100% next year

COIHY has less than 1 year of cash runway

Top 10 Correlated ETFs

COIHY

Top 10 Correlated Stocks

COIHY

In the News

COIHY Financial details

Company Rating

Strong Buy

Market Cap

8.19B

Income

320.85M

Revenue

3.1B

Book val./share

16.85

Cash/share

1.24

Dividend

0.66

Dividend %

2.21%

Employees

5.85K

Optionable

Shortable

Yes

Earnings

P/E

10.12

Forward P/E

PEG

-2

P/S

3.15

P/B

2.72

P/C

24.74

P/FCF

42.23

Quick Ratio

0.66

Current Ratio

2.38

Debt / Equity

0.27

LT Debt / Equity

0.25

EPS (TTM)

2.3

EPS next Y

EPS next Q

EPS this Y

-73.82%

EPS next Y

EPS next 5Y

EPS last 5Y

-6.75%

Revenue last 5Y

4.23%

Revenue Q/Q

-7.64%

EPS Q/Q

-6.35%

SMA20

-2.08%

SMA50

-2.41%

SMA100

2.32%

Inst Own

0.01%

Inst Trans

0.84%

ROA

18%

ROE

31%

ROC

0.14%

Gross Margin

47%

Oper. Margin

21%

Profit Margin

31%

Payout

22%

Shs Outstand

Shs Float

Target Price

52W Range

24.91-44.75

52W High

-30.27%

52W Low

+27.83%

RSI

54.94

Rel Volume

0.51

Avg Volume

17.62K

Volume

8.98K

Perf Week

5.54%

Perf Month

3.3%

Perf Quarter

20.88%

Perf Half Y

16.7%

Beta

0.713

Volatility

0.43%, 0.74%

Prev Close

2.13%

Price

30.68

Change

1.05%

COIHY Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	10.63	10.69	13.55	14.99	12.14
Net income per share	1.73	1.55	2.3	4.66	1.22
Operating cash flow per share	2.34	2.21	2.49	2.21	2.48
Free cash flow per share	1.49	1.28	1.35	1.12	1.12
Cash per share	0.63	0.82	0.81	2.3	1.24
Book value per share	6.65	12.2	12.57	17.33	16.85
Tangible book value per share	3.27	2.18	3.54	8.45	6.87
Share holders equity per share	6.65	12.2	12.57	17.33	16.85
Interest debt per share	5	7.14	6.89	4.48	4.76
Market cap	3.26B	4.28B	7.38B	4.63B	3.65B
Enterprise value	3.81B	5.08B	8.2B	4.93B	4.19B
P/E ratio	14.57	21.23	23	7.13	21.36
Price to sales ratio	2.37	3.08	3.9	2.22	2.16
POCF ratio	10.73	14.91	21.22	15.03	10.56
PFCF ratio	16.91	25.82	39.03	29.72	23.3
P/B Ratio	3.79	2.7	4.21	1.92	1.55
PTB ratio	3.79	2.7	4.21	1.92	1.55
EV to sales	2.76	3.65	4.34	2.36	2.47
Enterprise value over EBITDA	9.57	13.08	15	8.88	9.89
EV to operating cash flow	12.53	17.7	23.58	15.98	12.12
EV to free cash flow	19.75	30.64	43.39	31.62	26.73
Earnings yield	0.07	0.05	0.04	0.14	0.05
Free cash flow yield	0.06	0.04	0.03	0.03	0.04
Debt to equity	0.73	0.57	0.53	0.25	0.27
Debt to assets	0.33	0.3	0.28	0.17	0.18
Net debt to EBITDA	1.38	2.06	1.51	0.53	1.27
Current ratio	1.69	2.02	1.94	2.38	2.84
Interest coverage	17.29	13.81	17.05	53.58	11.44
Income quality	0.95	0.99	0.79	0.6	2.02
Dividend Yield	0.08	0.03	0.02	0.03	0.04
Payout ratio	1.19	0.57	0.41	0.22	0.88
Sales general and administrative to revenue	0.09	0.19	0.22	0.21	0.24
Research and developement to revenue	0.03	0.03	0.03	0.03	0.04
Intangibles to total assets	0.24	0.43	0.39	0.35	0.39
Capex to operating cash flow	-0.37	-0.42	-0.46	-0.49	-0.55
Capex to revenue	-0.08	-0.09	-0.08	-0.07	-0.11
Capex to depreciation	-1.67	-1.48	-1.4	-1.26	-1.5
Stock based compensation to revenue	0	0	0.02	-0.01	0
Graham number	16.08	20.63	25.5	42.62	21.55
ROIC	0.15	0.08	0.12	0.12	0.07
Return on tangible assets	0.15	0.12	0.16	0.28	0.08
Graham Net	-5.02	-7.43	-6.82	-2.56	-4.16
Working capital	231.2M	353.6M	433.8M	672.6M	589.2M
Tangible asset value	423.3M	283.4M	494.3M	1.18B	959.6M
Net current asset value	-454.8M	-734.8M	-633.8M	-20.4M	-301.7M
Invested capital	0.73	0.57	0.53	0.25	0.27
Average receivables	103.9M	243.95M	301.7M	342.5M	372.75M
Average payables	177.2M	202.2M	299.25M	339M	222.9M
Average inventory	278.05M	285.75M	372.8M	453.5M	402.6M
Days sales outstanding	55.05	73.54	62.45	63.19	82.67
Days payables outstanding	69.12	115.78	137.45	105.83	42.1
Days of inventory on hand	113.4	145.67	170.08	153.45	114.18
Receivables turnover	6.63	4.96	5.84	5.78	4.42
Payables turnover	5.28	3.15	2.66	3.45	8.67
Inventory turnover	3.22	2.51	2.15	2.38	3.2
ROE	0.26	0.13	0.18	0.27	0.07
Capex per share	-0.86	-0.93	-1.14	-1.09	-1.35

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric	2022-09-30	2022-12-31	2023-03-31	2023-06-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	3.45	6.93	3.15	6.31	5.83
Net income per share	0.38	0.76	0.32	0.63	0.59
Operating cash flow per share	0.82	1.67	0.52	1.07	1.41
Free cash flow per share	0.53	1.04	0.22	0.44	0.68
Cash per share	2.3	2.31	2.71	2.72	1.24
Book value per share	17.31	17.39	16.54	16.57	16.85
Tangible book value per share	8.44	8.48	8.15	8.16	6.87
Share holders equity per share	17.31	17.39	16.54	16.57	16.85
Interest debt per share	2.88	4.52	4.32	5.27	4.71
Market cap	4.48B	4.61B	4.53B	3.94B	3.65B
Enterprise value	4.16B	4.91B	4.15B	4.29B	4.19B
P/E ratio	21.2	10.9	25.69	11.19	11.02
Price to sales ratio	9.32	4.8	10.28	4.48	4.49
POCF ratio	39.29	19.83	62.79	26.43	18.59
PFCF ratio	60.61	32.06	145.09	64.02	38.38
P/B Ratio	1.86	1.91	1.96	1.71	1.55
PTB ratio	1.86	1.91	1.96	1.71	1.55
EV to sales	8.66	5.1	9.42	4.87	5.15
Enterprise value over EBITDA	48.45	18.97	37.38	19.58	21.22
EV to operating cash flow	36.48	21.1	57.52	28.77	21.32
EV to free cash flow	56.27	34.11	132.93	69.69	44.03
Earnings yield	0.01	0.02	0.01	0.02	0.02
Free cash flow yield	0.02	0.03	0.01	0.02	0.03
Debt to equity	0.17	0.25	0.26	0.32	0.27
Debt to assets	0.11	0.17	0.17	0.21	0.18
Net debt to EBITDA	-3.73	1.14	-3.42	1.59	2.72
Current ratio	2.38	2.38	3.46	3.46	2.84
Interest coverage	0	17	0	24.42	6.76
Income quality	2.16	2.2	1.64	1.69	2.37
Dividend Yield	0.01	0.01	0.01	0.02	0.02
Payout ratio	0.62	0.62	0.97	0.97	0.79
Sales general and administrative to revenue	0.21	0.15	0	0	0
Research and developement to revenue	0.09	0.04	0	0	0
Intangibles to total assets	0.35	0.35	0.34	0.34	0.39
Capex to operating cash flow	-0.35	-0.38	-0.57	-0.59	-0.52
Capex to revenue	-0.08	-0.09	-0.09	-0.1	-0.12
Capex to depreciation	-3.51	-1.48	-1.35	-1.45	-1.54
Stock based compensation to revenue	0.01	0.01	0	0	0
Graham number	12.15	17.27	10.83	15.34	15
ROIC	0.02	0.05	0.02	0.03	0.03
Return on tangible assets	0.02	0.04	0.02	0.04	0.04
Graham Net	-2.81	-2.57	-2.5	-2.51	-4.15
Working capital	672.6M	672.6M	827.9M	827.9M	589.2M
Tangible asset value	1.18B	1.18B	1.14B	1.14B	959.6M
Net current asset value	-20.4M	-20.4M	-48.7M	-48.7M	-301.7M
Invested capital	0.17	0.25	0.26	0.32	0.27
Average receivables	393.6M	338.15M	363.5M	365.3M	0
Average payables	239.65M	220.45M	290.3M	260.6M	0
Average inventory	449.4M	464M	441.75M	419.5M	0
Days sales outstanding	58.86	33.84	74.64	37.32	42.46
Days payables outstanding	42.47	50.32	94.12	41.96	21.29
Days of inventory on hand	163	72.97	151.5	67.55	57.74
Receivables turnover	1.53	2.66	1.21	2.41	2.12
Payables turnover	2.12	1.79	0.96	2.14	4.23
Inventory turnover	0.55	1.23	0.59	1.33	1.56
ROE	0.02	0.04	0.02	0.04	0.04
Capex per share	-0.29	-0.64	-0.29	-0.63	-0.73

COIHY Dividend History

COIHY Frequently Asked Questions

What is Croda International Plc stock symbol ?

Croda International Plc is a GB stock and trading under the symbol COIHY

What is Croda International Plc stock quote today ?

Croda International Plc stock price is $30.68 today.

Is Croda International Plc stock public?

Yes, Croda International Plc is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 17.62K
Market Capitalization 8.19B
Employee 5.85K
CEO Mr. Stephen Edward Foots
Headquarters Goole,GB
IPO Date 2012-08-03
Website https://www.croda.com

Croda International Plc creates, makes, and sells specialty chemicals in Europe, the Middle East, Africa, North America, Asia, and Latin America. It operates through four segments: Consumer Care, Life Sciences, Performance Technologies, and Industrial Chemicals. The company offers adhesives; crop protection additives and adjuvants, seed enhancement and animal health chemicals, chemical bio-stimulants, and specialty additives for agricultural films; and lubricant additives, coatings and polymers, vehicle cleaning chemicals, and products for automotive textiles and fibers, as well as specialty additives for plastics, and battery and catalyst industries. It also provides specialty ingredients for self-tanning, color cosmetics, bath and shower, deodorants, anti-perspirants, depilatories, men's grooming, and oral hygiene, as well as skin, hair, sun, body, and baby care applications; construction chemicals and bitumen additives; dietary supplements; and materials and polymer additives for electronics and devices. In addition, the company offers chemistries, emulsifiers, fuel and power generation additives, and polymer additives; food additives; specialty polymer additives for furniture and wood applications; household, industrial, and institutional cleaning products; lubricants; oleochemicals; and packaging, print, and paper chemicals. Further, it provides paints and coatings; active pharmaceutical ingredients; thermal management products; plastic and rubber products; skin health products; hygiene and industrial nonwovens, botanical extracts, tissues, and textile auxiliaries; and water treatment chemicals. Additionally, the company offers bio-based phase change materials for buildings and ventilation, clothing and healthcare, electronics and devices, food and refrigeration, energy storage and recovery, temperature controlled packaging, and vehicles and automotive applications. The company was incorporated in 1925 and is headquartered in Goole, the United Kingdom.